Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Condition(s):Porphyria Cutanea TardaLast Updated:February 17, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Porphyria Cutanea TardaLast Updated:February 17, 2023Completed
Condition(s):Acute Hepatic PorphyriaLast Updated:March 12, 2024Recruiting
Condition(s):Acute Intermittent Porphyria (AIP)Last Updated:April 14, 2023Recruiting
Condition(s):Acute Intermittent PorphyriaLast Updated:January 23, 2023Active, not recruiting
Condition(s):Acute Hepatic PorphyriaLast Updated:July 18, 2022No longer available
Condition(s):Porphyria Cutanea TardaLast Updated:February 10, 2014Completed
Condition(s):Porphyria Cutanea TardaLast Updated:September 21, 2005Completed
Condition(s):Porphyrias, HepaticLast Updated:May 31, 2023Recruiting
Condition(s):Acute Hepatic PorphyriaLast Updated:June 16, 2021Unknown status
Condition(s):Acute Hepatic PorphyriaLast Updated:May 17, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.